(Q54375435)

29 May 2018

title

Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels (English)

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

11 December 2024

1 reference

7

Marsha A Moses

1 reference

29 May 2018

Ursula A. Matulonis

6

object named as

Ursula A Matulonis

1 reference

29 May 2018

author name string

David Zurakowski

3

1 reference

29 May 2018

Jiang Yang

4

1 reference

29 May 2018

Christine M. Coticchia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21889192

11 December 2024

Adam S. Curatolo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21889192

11 December 2024

Kathryn E. Daniels

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21889192

11 December 2024

language of work or name

English

0 references

publication date

1 September 2011

1 reference

29 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0090825811005841?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

https://api.elsevier.com/content/article/PII:S0090825811005841?httpAccept=text/plain

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

11 December 2024

1 reference

29 May 2018

volume

123

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

295-300

1 reference

29 May 2018

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

1 reference

Rational use of cytotoxic chemotherapy for recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Diagnostic markers for early detection of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Development of a multimarker assay for early detection of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

The CA 125 tumour-associated antigen: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Urinary biomarkers predict brain tumor presence and response to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Making the cut: protease-mediated regulation of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Lipocalin 2 promotes breast cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Lipocalin 2: a multifaceted modulator of human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Ovarian cancer: relevant therapy, not timing, is paramount

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.034

Validation of serum biomarkers for detection of early-stage ovarian cancer

7 January 2021

3

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

CA125 antigen levels in obstetric and gynecologic patients

11 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas

11 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

Increased incidence of matrix metalloproteinases in urine of cancer patients

11 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma

11 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses

11 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.07.034

11 December 2024

Identifiers

1 reference

29 May 2018

1 reference

29 May 2018